Effects of silver-based wound dressings on the bacterial flora in chronic leg ulcers and its susceptibility in vitro to silver

Acta Dermato-Venereologica

Volumn 92, Issue 1, 2012, Pages 34-39

  Sütterlin, Susanne ^a   Tano, Eva ^a   Bergsten, Agneta ^b   Tallberg, Anna Brita ^c   Melhus, Åsa ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Derepressed mutant; ESBL; Silver; Silver resistance; Wound dressing

Indexed keywords

CEPHALOSPORIN; CLINDAMYCIN; FLUCLOXACILLIN; IMIPENEM; MEROPENEM; SILVER NITRATE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL FLORA; BACTERIOSTASIS; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MONITORING; GENETIC RESISTANCE; HUMAN; IN VITRO STUDY; LEG ULCER; MINIMUM INHIBITORY CONCENTRATION; PHENOTYPE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TREATMENT DURATION; WOUND DRESSING;

ANTI-BACTERIAL AGENTS; BANDAGES; CARBOXYMETHYLCELLULOSE SODIUM; CEPHALOSPORIN RESISTANCE; CHRONIC DISEASE; DRUG CARRIERS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTER CLOACAE; GENES, BACTERIAL; HUMANS; KLEBSIELLA PNEUMONIAE; LEG ULCER; MICROBIAL SENSITIVITY TESTS; POLYESTERS; POLYETHYLENES; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS, DNA; SILVER NITRATE; STAPHYLOCOCCUS AUREUS;

EID: 84855233222     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1170     Document Type: Article

References (33)

1. Landsdown AB, Williams A. Bacterial resistance to silver in wound care and medical devices. J Wound Care 2007; 16: 15-19.
2. Klasen HJ. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 2000; 26: 131-138.
3. Chambers H, Dumville JC, Cullum N. Silver treatments for leg ulcers: a systematic review. Wound Repair Regen 2007; 15: 165-173.
4. Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 2010; 74: 417-433.
5. Percival SL, Bowler PG, Russell D. Bacterial resistance to silver in wound care. J Hosp Infect 2005; 60: 1-7.
6. Cutting K, White R, Edmonds M. The safety and efficacy of dressings with silver-addressing clinical concerns. Int Wound J 2007; 4: 177-184.
7. Mayer KH, Hopkins JD, Gilleece ES, Chao L, O'Brien TF. Molecular evolution, species distribution, and clinical consequences of an endemic aminoglycoside resistance plasmid. Antimicrob Agents Chemother 1986; 29: 628-633.
8. Pirnay JP, De Vos D, Cochez C, Bilocq F, Pirson J, Struelens M, et al. Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone. J Clin Microbiol 2003; 41: 1192-1202.
9. Gupta A, Matsui K, Lo JF, Silver S. Molecular basis for resistance to silver cations in Salmonella. Nat Med 1999; 5: 183-188.
10. Gupta A, Phung LT, Taylor DE, Silver S. Diversity of silver resistance genes in IncH incompatibility group plasmids. Microbiology 2001; 147: 3393-3402.
11. Johnson TJ, Siek KE, Johnson SJ, Nolan LK. DNA sequence and comparative genomics of pAPEC-O2-R, an avian pathogenic Escherichia coli transmissible R plasmid. Antimicrob Agents Chemother 2005; 49: 4681-4688.
12. Kaur P, Vadehra DV. Mechanism of resistance to silver ions in Klebsiella pneumoniae. Antimicrob Agents Chemother 1986; 29: 165-167.
13. Li XZ, Nikaido H, Williams KE. Silver-resistant mutants of Escherichia coli display active efflux of Ag+ and are deficient in porins. J Bacteriol 1997; 179: 6127-6132.
14. SCENIHR, European Commission. Assessment of the antibiotic resistance effects of biocides. 2009. Available from: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/ docs/scenihr_o_021.pdf.
15. Schierholz JM, Wachol-Drewek Z, Lucas LJ, Pulverer G. Activity of silver ions in different media. Zentralbl Bakteriol 1998; 287: 411-420.
16. Brett DW. A discussion of silver as an antimicrobial agent: alleviating the confusion. Ostomy Wound Manage 2006; 52: 34-41.
17. Sibbald RG, Contreras-Ruiz J, Coutts P, Fierheller M, Rothman A, Woo K. Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers. Adv Skin Wound Care 2007; 20: 549-558.
18. Chopra I. The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern? J Antimicrob Chemother 2007; 59: 587-590.
19. Percival SL, Woods E, Nutekpor M, Bowler P, Radford A, Cochrane C. Prevalence of silver resistance in bacteria isolated from diabetic foot ulcers and efficacy of silver-containing wound dressings. Ostomy Wound Manage 2008; 54: 30-40.
20. Mahenthiralingam E, Campbell ME, Foster J, Lam JS, Speert DP. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J Clin Microbiol 1996; 34: 1129-1135.
21. McHugh GL, Moellering RC, Hopkins CC, Swartz MN. Salmonella typhimurium resistant to silver nitrate, chloramphenicol, and ampicillin. Lancet 1975; 1: 235-240.
22. Gayle WE, Mayhall CG, Lamb VA, Apollo E, Haynes BW Jr. Resistant Enterobacter cloacae in a burn center: the ineffectiveness of silver sulfadiazine. J Trauma 1978; 18: 317-323.
23. Hendry AT, Stewart IO. Silver-resistant Enterobacteriaceae from hospital patients. Can J Microbiol 1979; 25: 915-921.
24. Starodub ME, Trevors JT. Silver resistance in Escherichia coli R1. J Med Microbiol 1989; 29: 101-110.
25. Bridges K, Kidson A, Lowbury EJ, Wilkins MD. Gentamicin-and silver-resistant pseudomonas in a burns unit. Br Med J 1979; 1: 446-449.
26. Ip M, Lui SL, Chau SS, Lung I, Burd A. The prevalence of resistance to silver in a Burns unit. J Hosp Infect 2006; 63: 342-344.
27. Loh JV, Percival SL, Woods EJ, Williams NJ, Cochrane CA. Silver resistance in MRSA isolated from wound and nasal sources in humans and animals. Int Wound J 2009; 6: 32-38.
28. Carter MJ, Tingley-Kelley K, Warriner RA 3rd. Silver treatments and silver-impregnated dressings for the healing of leg wounds and ulcers: a systematic review and metaanalysis. J Am Acad Dermatol 2010; 63: 668-679.
29. Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil 1999; 20: 195-200.
30. Tredget EE, Shankowsky HA, Groeneveld A, Burrell R. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds. J Burn Care Rehabil 1998; 19: 531-537.
31. Martinez-Martinez L. Extended-spectrum beta-lactamases and the permeability barrier. Clin Microbiol Infect 2008; 14 Suppl 1: 82-89.
32. Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev 2009; 22: 161-182.
33. Lytsy B, Sandegren L, Tano E, Torell E, Andersson DI, Melhus Å. The first major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTXM-15. APMIS 2008; 116: 302-308.